)
)
Edge16 Oct 2026
Winner, Winner: The Chicken McNugget Story
How a 1940s breeding contest, a Cornell food scientist, and a hedge by Ray Dalio helped McDonald's turn the Chicken McNugget into a fast-food icon.
S2Medical
S2Medical (S2M) investor relations material
S2Medical H1 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.H1 2026 earnings summary21 Aug, 2026
Executive summary
Net sales for the first half of 2026 increased to 7.4 MSEK from 6.9 MSEK year-over-year, driven by higher sales through the Abena partnership and core products.
Operating result improved to 0.2 MSEK from -0.5 MSEK, reflecting cost optimizations and lower external costs.
Net profit for the period was 0.2 MSEK, unchanged from the previous year.
The company maintained a cost-neutral operation while advancing its technology and product portfolio.
Financial highlights
Net sales: 7.4 MSEK (up from 6.9 MSEK year-over-year).
Operating result: 0.2 MSEK (improved from -0.5 MSEK year-over-year).
Net profit: 0.2 MSEK (unchanged year-over-year).
Earnings per share: 0.00 SEK (unchanged year-over-year).
Cash flow for the period: -0.3 MSEK (down from 0.3 MSEK year-over-year).
Cash and cash equivalents at period end: 0.6 MSEK.
Equity ratio at period end: 60%.
Outlook and guidance
The company aims to leverage its validated patent portfolio and product pipeline for future growth.
Proceeds from the upcoming rights issue will be used to accelerate revenue-generating activities and product development.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from S2Medical
- Net loss of -10.1 MSEK driven by write-downs, with focus shifting to antimicrobial peptide technology.S2M
H2 2025 - Net sales doubled to 6.9 MSEK, but net profit dropped due to non-recurring income last year.S2MH1 2025
- Strong turnaround with positive net income, debt-free status, and strategic acquisition.S2MQ2 2024
- 2024 saw doubled sales, positive earnings, and strategic expansion into cosmetics and new tech.S2MQ4 2024
Next S2Medical earnings date
H2 202620 Feb, 2027
S2Medical
Next S2Medical earnings date
H2 202620 Feb, 2027
AI chat
Ask anything. Verify everything.
Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn moreFind what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.)
Trust every finding
50m+ first-party documents. Every output traceable to its source.Find what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.Trust every finding
50m+ first-party documents. Every output traceable to its source.Automations
Zero in on what matters
Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more)
Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.)
Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Live audio & transcripts
Be first
Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more)
Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.)
Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Quartr MCP connects your AI environment to 17K+ public companies
Pull live transcripts, filings, and slides into Claude or Codex via MCP. Combine Quartr's global IR data with any other dataset. Run agentic research and monitoring.
Included with Quartr Pro at no extra cost.Learn more
Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.
Jamie Ross
Investment Manager, GAM Investments
GAM
GAM
Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.
Tom O'Hara
Investment Director
Ciena
Ciena
Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.
Gregg Lampf
VP of Investor Relations
Protean
Protean
Being able to ask specific questions across years of transcripts and reports and instantly get verified answers is a game-changer.
Pontus Dackmo
CEO & Investment Manager
)
)
Frequently asked questions
S2Medical AB is a Swedish medical technology company specializing in wound care solutions, particularly for burns and chronic wounds. The company develops, produces, and markets a range of innovative products that cover the entire wound healing process. Their portfolio includes INSTAQRETT, a sterile single-use mechanical debridement tool, and the Epiprotect line, which features synthetic substitutes for allografts and xenografts, ulcer dressings, and blood-stilling membranes. Additionally, they distribute Silverlon antimicrobial dressings in the Nordic countries and operate the S2Clinic, a wound healing center in Sweden. The company is headquartered in Linköping, Sweden, and its shares are listed on the Nasdaq Stockholm.